Compare UAN & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UAN | BLFS |
|---|---|---|
| Founded | 2007 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 923.5M |
| IPO Year | 2008 | 2013 |
| Metric | UAN | BLFS |
|---|---|---|
| Price | $129.22 | $18.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 99.8K | ★ 485.3K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.03% | N/A |
| EPS Growth | 61.98 | ★ 77.27 |
| EPS | ★ 9.33 | N/A |
| Revenue | ★ $606,038,000.00 | $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | $14.18 | ★ N/A |
| Revenue Growth | 15.36 | ★ 16.97 |
| 52 Week Low | $63.45 | $17.86 |
| 52 Week High | $139.50 | $29.57 |
| Indicator | UAN | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 58.87 | 37.80 |
| Support Level | $89.52 | $17.86 |
| Resistance Level | $139.50 | $25.95 |
| Average True Range (ATR) | 7.23 | 0.89 |
| MACD | 0.97 | 0.00 |
| Stochastic Oscillator | 68.95 | 26.21 |
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.